{"count": 3, "results": [{"_id": "10930569", "pmid": 10930569, "title": "Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice.", "journal": "FEBS Lett", "authors": ["Cartier N", "Guidoux S", "Rocchiccioli F", "Aubourg P"], "date": "2000-08-04T00:00:00Z", "doi": "10.1016/s0014-5793(00)01852-4", "meta_date_publication": "2000 Aug 4", "meta_volume": "478", "meta_issue": "3", "meta_pages": "205-8", "score": 50083.418, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ does not normalize very long chain fatty acids in @<m>DISEASE_Adrenoleukodystrophy</m> @DISEASE_MESH:D000326 @@@adrenoleukodystrophy@@@ @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Cartier N, Guidoux S, Rocchiccioli F, Aubourg P. Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice. FEBS Lett. 2000 Aug 4;478(3):205-8. PMID: 10930569", "BibTeX": "@article{10930569, title={Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice.}, author={Cartier N and Guidoux S and Rocchiccioli F and Aubourg P}, journal={FEBS Lett}, volume={478}, number={3}, pages={205-8}}"}}, {"_id": "11136559", "pmid": 11136559, "title": "Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment.", "journal": "Mol Genet Metab", "authors": ["Di Biase A", "Salvati S", "Varí R", "Avellino C", "Sforza F", "Cappa M", "Masella R"], "date": "2000-12-01T00:00:00Z", "doi": "10.1006/mgme.2000.3100", "meta_date_publication": "2000 Dec", "meta_volume": "71", "meta_issue": "4", "meta_pages": "651-5", "score": 50076.746, "text_hl": "Susceptibility to oxidation of plasma low-density lipoprotein in @<m>DISEASE_Adrenoleukodystrophy</m> @DISEASE_MESH:D000326 @@@X-linked adrenoleukodystrophy@@@: effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment.", "citations": {"NLM": "Di Biase A, Salvati S, Varí R, Avellino C, Sforza F, Cappa M, Masella R. Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment. Mol Genet Metab. 2000 Dec;71(4):651-5. PMID: 11136559", "BibTeX": "@article{11136559, title={Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment.}, author={Di Biase A and Salvati S and Varí R and Avellino C and Sforza F and Cappa M and Masella R}, journal={Mol Genet Metab}, volume={71}, number={4}, pages={651-5}}"}}, {"_id": "11757591", "pmid": 11757591, "title": "Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.", "journal": "J Inherit Metab Dis", "authors": ["Rubio-Gozalbo ME", "van Waardenburg DA", "Forget PP", "Spaapen LJ", "Verrips A", "Vroomen PC"], "date": "2001-10-01T00:00:00Z", "doi": "10.1023/a:1012480130445", "meta_date_publication": "2001 Oct", "meta_volume": "24", "meta_issue": "5", "meta_pages": "605-6", "score": 50068.184, "text_hl": "An 8 year-old boy with @<m>DISEASE_Adrenoleukodystrophy</m> @DISEASE_MESH:D000326 @@@X-ALD@@@ under treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ developed a severe adverse reaction when the dose of his other medication, @CHEMICAL_Clopenthixol @CHEMICAL_MESH:D003006 @@@zuclopenthixol@@@ was increased. ", "citations": {"NLM": "Rubio-Gozalbo ME, van Waardenburg DA, Forget PP, Spaapen LJ, Verrips A, Vroomen PC. Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy. J Inherit Metab Dis. 2001 Oct;24(5):605-6. PMID: 11757591", "BibTeX": "@article{11757591, title={Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.}, author={Rubio-Gozalbo ME and van Waardenburg DA and Forget PP and Spaapen LJ and Verrips A and Vroomen PC}, journal={J Inherit Metab Dis}, volume={24}, number={5}, pages={605-6}}"}}]}